EUVIMEDEUVIMED entdecken
Leserbrief

Comments on: Predictors of pathologic complete response in early-stage triple-negative breast cancer treated with neoadjuvant chemo-immunotherapy

Rajesh Prasad Jayaswal, Shailendra Thapliyal, Rama Kumari Badyal

Breast Cancer Research and Treatment · 2026-06 · 217 (3)

DOI: 10.1007/s10549-026-08015-2 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Breast Cancer Research and Treatment, online erschienen am 26.06.2026. Verfasst von Rajesh Prasad Jayaswal und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory Sciences, University Institute of Allied Health Sciences, Chandigarh University, Mohali, Punjab, 140413, India. rpja…. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Immunotherapy, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit nennt 3 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This correspondence comments on LeVee et al.'s real-world study of neoadjuvant chemo-immunotherapy in early-stage triple-negative breast cancer. We highlight diabetes as a potentially modifiable host-state factor influencing pathologic complete response and propose a metabolic immunotherapy-readiness framework integrating glycaemic control, treatment delivery, endocrine monitoring, and equity-focused implementation. This perspective aims to support globally applicable strategies for improving chemo-immunotherapy effectiveness and access.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsImmunotherapyAntineoplastic Combined Chemotherapy ProtocolsHumansNeoadjuvant TherapyPathologic Complete ResponseFemaleNeoplasm StagingTreatment Outcome

Stichwörter der Autor:innen

DiabetesMetabolic immunotherapy readinessNeoadjuvant chemo-immunotherapyPathologic complete responsePembrolizumabTriple-negative breast cancer

Autor:innen und Institutionen

  • Department of Medical Laboratory Sciences, University Institute of Allied Health Sciences, Chandigarh University, Mohali, Punjab, 140413, India. rpjayaswal.jec@gmail.com.
  • Uttaranchal Institute of Technology, Uttaranchal University, Dehradun, Uttarakhand, 248007, India.
  • Department of Pathology, Govt. Medical College/Rajindra Hospital, Patiala, Punjab, 147001, India.

Zitieren

APA

Jayaswal, R. P., Thapliyal, S., & Badyal, R. K. (2026). Comments on: Predictors of pathologic complete response in early-stage triple-negative breast cancer treated with neoadjuvant chemo-immunotherapy. Breast Cancer Research and Treatment, 217(3). https://doi.org/10.1007/s10549-026-08015-2

Vancouver

Jayaswal RP, Thapliyal S, Badyal RK. Comments on: Predictors of pathologic complete response in early-stage triple-negative breast cancer treated with neoadjuvant chemo-immunotherapy. Breast Cancer Research and Treatment. 2026;217(3). doi:10.1007/s10549-026-08015-2

BibTeX
@article{Jayaswal2026,
  author = {Jayaswal, Rajesh Prasad and Thapliyal, Shailendra and Badyal, Rama Kumari},
  title = {Comments on: Predictors of pathologic complete response in early-stage triple-negative breast cancer treated with neoadjuvant chemo-immunotherapy},
  journal = {Breast Cancer Research and Treatment},
  year = {2026},
  volume = {217},
  number = {3},
  doi = {10.1007/s10549-026-08015-2}
}
Kostenlos starten →